Statistics
Publications
59
Citations
3.8K
H-Index
32
Active since
1975
Martin Vanderlaan is an author at Lawrence Livermore National Laboratory specializing in biochemistry, pharmacy, and antibody characterization.
Publications per year
1975–2019
59
59
Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro
Yaning Wang, David Fei, Martin Vanderlaan et al. · Angiogenesis · 2004 · 437 citations
Medicine, Cancer Biology, Oncology +14
Cytochemistry for bromodeoxyuridine/DNA analysis: Stoichiometry and sensitivity
Frank Dolbeare, Wolfgang Beisker, Maria G. Pallavicini et al. · Cytometry · 1985 · 147 citations
Medicine, Biochemistry, Cell Biology +15
Effect of carcinogens on chicken atherosclerosis.
Roy E. Albert, Martin Vanderlaan, Fredric J. Burns et al. · PubMed · 1977 · 127 citations
1–5 of 59